| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2013 | EP2538930A1 Formulations for oral delivery of adsorbents in the gut |
| 01/02/2013 | EP2538929A2 Sustained delivery of therapeutic agents to an eye compartment |
| 01/02/2013 | EP2538928A2 Abuse-resistant formulations |
| 01/02/2013 | EP2538926A2 Veterinary compositions |
| 01/02/2013 | EP2538925A2 Apixaban formulations |
| 01/02/2013 | EP2538924A2 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 01/02/2013 | EP2538923A2 Taste-masked powder for suspension compositions of methylprednisolone |
| 01/02/2013 | EP2538922A1 Formulation of compositions for the treatment of inflammatory conditions |
| 01/02/2013 | EP2538919A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 01/02/2013 | EP2538918A1 Citicoline for the treatment of glaucoma and ocular hypertension |
| 01/02/2013 | EP2538804A1 Beverage |
| 01/02/2013 | EP2538803A1 Formulations and methods for nutrient delivery |
| 01/02/2013 | EP2538790A1 Virus-inactivating composition containing low-molecular weight compound and arginine |
| 01/02/2013 | EP2538785A1 Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |
| 01/02/2013 | EP2538784A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 01/02/2013 | EP2538783A1 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
| 01/02/2013 | EP2538780A1 Estrogen receptor ligands and methods of use thereof |
| 01/02/2013 | EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 01/02/2013 | EP1598422B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 01/02/2013 | CN202637539U Novel rheumatism analgesic ointment |
| 01/02/2013 | CN202637538U Rheumatic pain relieving paste |
| 01/02/2013 | CN202637533U Compound bismuth potassium citrate capsule |
| 01/02/2013 | CN202637496U Device for preparation of dithio heterocyclic ring pentene and pyrrole ketone compound nanoparticles |
| 01/02/2013 | CN1995022B Process for the synthesis of nucleoside analogues |
| 01/02/2013 | CN1919846B Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 01/02/2013 | CN1823041B 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/02/2013 | CN102858979A Treatment Of Fibroblast Growth Factor 21 (FGF21) Related Diseases By Inhibition Of Natural Antisense Transcript To FGF21 |
| 01/02/2013 | CN102858790A Nucleoside Phosphoramidates |
| 01/02/2013 | CN102858783A Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 01/02/2013 | CN102858782A 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | CN102858779A Cyclic tetrapeptides and therapeutic applications thereof |
| 01/02/2013 | CN102858778A Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 01/02/2013 | CN102858777A Pyrazolopyridazine derivatives for the treatment of hepatitis C |
| 01/02/2013 | CN102858776A Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin V1a receptor antagonists |
| 01/02/2013 | CN102858775A Pyrrazolopyridine derivatives |
| 01/02/2013 | CN102858774A Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/02/2013 | CN102858773A Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/02/2013 | CN102858772A Imidazo[1,2-a]pyridine derivative |
| 01/02/2013 | CN102858771A 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as HIV integrase inhibitor |
| 01/02/2013 | CN102858770A Bicyclic Compounds And Their Uses As Dual C-src / Jak Inhibitors |
| 01/02/2013 | CN102858769A Pyrazolopyridine kinase inhibitors |
| 01/02/2013 | CN102858768A Substituted triazolopyridines |
| 01/02/2013 | CN102858767A Aminopyrimidines as SYK inhibitors |
| 01/02/2013 | CN102858766A Polymorphs of a metabotropic glutamate receptor positive allosteric modulator |
| 01/02/2013 | CN102858765A Pyrazolyl quinazoline kinase inhibitors |
| 01/02/2013 | CN102858764A Pyrimidinyl indole compounds |
| 01/02/2013 | CN102858763A Prolylhydroxylase inhibitors and methods of use |
| 01/02/2013 | CN102858762A Novel salts for the manufacture of pharmaceutical compositions |
| 01/02/2013 | CN102858760A Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 01/02/2013 | CN102858754A RAF inhibitor compounds and methods of use thereof |
| 01/02/2013 | CN102858753A Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 01/02/2013 | CN102858751A Cysteine protease inhibitors |
| 01/02/2013 | CN102858748A Therapeutic agent and preventative agent for Alzheimer's disease |
| 01/02/2013 | CN102858746A Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/02/2013 | CN102858745A Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
| 01/02/2013 | CN102858744A Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use |
| 01/02/2013 | CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102858376A Method For Proliferating Cardiomyocytes Using Micro-RNA |
| 01/02/2013 | CN102858372A Skin irritation suppressant and transdermal preparation |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102858356A Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 01/02/2013 | CN102858354A Infant and young children feeding formula comprising probiotics for infants and young children |
| 01/02/2013 | CN102858348A Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 01/02/2013 | CN102858347A Polyimidazoles for use as bile acid sequestrants |
| 01/02/2013 | CN102858346A Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol |
| 01/02/2013 | CN102858345A Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same |
| 01/02/2013 | CN102858344A Deuterated 5,6-dihydro-1h-pyridin-2-one Compounds |
| 01/02/2013 | CN102858343A Methods and compositions for treating or preventing symptoms of hormonal variations |
| 01/02/2013 | CN102858342A Arylvinylazacycloalkane compounds for constipation |
| 01/02/2013 | CN102858341A Synergistic fungicidal composition containing 5-fluorocytosine for fungal control in cereals |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102858339A Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain |
| 01/02/2013 | CN102858338A Pharmaceutical Compositions For The Treatment Of Pain And Other Indicatons |
| 01/02/2013 | CN102858337A Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 01/02/2013 | CN102858336A Treatment of dermatological allergic conditions |
| 01/02/2013 | CN102858335A Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 01/02/2013 | CN102858334A Composition for amelioration of hypoalbuminemia |
| 01/02/2013 | CN102858333A Treatment of respiratory disorders |
| 01/02/2013 | CN102858332A Ketoprofen-containing aqueous adhesive skin patch |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102858330A Process for the production of ralfinamide methanesulfonate salts or their R-enantiomers |
| 01/02/2013 | CN102858329A Compounds for use in the treatment of diseases |
| 01/02/2013 | CN102858328A Thioxanthone-based autophagy inhibitor therapies to treat cancer |
| 01/02/2013 | CN102858327A Oral dosage forms |
| 01/02/2013 | CN102858325A Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
| 01/02/2013 | CN102858324A Double-layer pharmaceutical formulations containing opioid agonists and antagonists |
| 01/02/2013 | CN102858323A Anticancer drug delivery system using ph-sensitive metal nanoparticles |
| 01/02/2013 | CN102858321A Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives |
| 01/02/2013 | CN102858191A Use of 6'-sialyl lactose in infant and toddler nutrition |
| 01/02/2013 | CN102858177A Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/02/2013 | CN102858176A Analgesic compounds, compositions, and uses thereof |
| 01/02/2013 | CN102858175A Triazolones as fatty acid synthase inhibitors |
| 01/02/2013 | CN102858159A Chemical compounds |
| 01/02/2013 | CN102858158A Compositions of small molecule therapeutics |
| 01/02/2013 | CN102858156A Methods, compositions and kits for providing a therapeutic treatment |
| 01/02/2013 | CN102858155A Methods of using diacerein as an adjunctive therapy for diabetes |
| 01/02/2013 | CN102858154A Estrogen receptor ligands and methods of use thereof |
| 01/02/2013 | CN102851295A Toll-like receptor regulatory oligonucleotide and application thereof |
| 01/02/2013 | CN102851268A Crystal structure of enterovirus 71 3C protease and application thereof |